4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001553338-25-000005
Director sold 8,367 shares at an average $67.65 ($566,038)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Waddill William D. · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-19 | Sale : show line 1 in the form 10b5-1 | −2,416 | $66.66 | $161,051 | 62,514 | D |
| 2025-12-19 | Sale : show line 2 in the form 10b5-1 | −5,451 | $68.01 | $370,723 | 57,063 | D |
| 2025-12-19 | Sale : show line 3 in the form 10b5-1 | −500 | $68.53 | $34,265 | 56,563 | D |
| Open-market sales · 8,367 sh · avg $67.65 · $566,038 | ||||||
Loading xslF345X05/wk-form4_1766530901.xml…